NYSE:BHC (Bausch Health Companies Inc.)

About BHC

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
  • Bausch Health Companies Inc. (NYSE: BHC) Latest News

    The Motley Fool
    Investing

    Has Valeant Pharmaceuticals Intl Inc. Hit the Bottom Yet?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may have lost over 90% in value over the past year, but the company continues…

    Read more »

    The Motley Fool
    Investing

    What Can Investors Expect From Valeant Pharmaceuticals Intl Inc.?

    Because of high debt, a money-losing partnership, and questions about whether or not insiders have faith, I say avoid Valeant…

    Read more »

    The Motley Fool
    Investing

    How Valeant Pharmaceuticals Intl Inc. Could Become a Great Investment

    Beleaguered Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is starting to make amends for the epic collapse of the stock over the…

    Read more »

    Investing

    3 Companies Actually Investing in the Future

    While analysts at the Bank of Canada and big banks such as Canadian Imperial Bank of Commerce (TSX:CM)(NYSE:CM) are seeing…

    Read more »

    The Motley Fool
    Dividend Stocks

    Brexit: 4 Negative Effects on the Stock Market

    The Brexit added volatility to the stock market, but selective groups of stocks are more vulnerable to declines, including cyclical…

    Read more »

    The Motley Fool
    Investing

    Can Investors Expect Anything Good From Valeant Pharmaceuticals Intl Inc.?

    While Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) won't default, it needs to show that it can be profitable and pay down…

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Recover?

    Shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) tumbled this week on reports that it cut 2016 profit forecasts, prompting investors…

    Read more »

    The Motley Fool
    Investing

    3 TSX Stocks That Are Down but Not out

    There are 32 TSX stocks down at least 5% year-to-date, including Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), which is off a…

    Read more »

    The Motley Fool
    Investing

    Has the Worst Passed for Valeant Pharmaceuticals Intl Inc.?

    After what can only be described as an epic collapse, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:NRX) may have turned the first…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is It Going to Default?

    While Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) received a default notice, I expect it to be just fine, and it might…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Cleans Shop. Is it a Buy Now?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is looking to turn around with operational changes. However, it's not a buy until it…

    Read more »

    The Motley Fool
    Energy Stocks

    Will These 3 Struggling Stocks Survive 2016?

    This year could be fatal for Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE), Sears Canada Inc. (TSX:SCC), and Valeant Pharmaceuticals Intl Inc.…

    Read more »